60 likes | 79 Views
Microalbuminuria is a condition that affects the kidney and restricts in retaining serum albumin, which is considered as a vital factor for the kidney to maintain its overall health of the body.
E N D
MICROALBUMINURIA MARKET Global Industry Analysis, Size, Share, Analysis, Growth, Forecast 2017 - 2025 Trends, and TMR Research www.tmrresearch.com
MICROALBUMINURIA MARKET 1MARKETOVERVIEW Albumin is a commonly found protein in the blood and constitutes around 50% of the blood protein. Microalbuminuria refers to a condition in which kidney is not able to retain serum albumin, which is essential for the kidney to maintain overall health of the body, and exerts it in the urine. During certain conditions like diabetes, especially type 1 patients, nephropathy, and other nephrotic syndromes, the chances escalated. of microalbuminuria is TMR Research www.tmrresearch.com
MICROALBUMINURIA MARKET 2KEY TRENDS Elderly people are more prone to diabetic diseases. According to the National Institute of Aging (NIH), 524 million people were aged over 65 across the globe and this number is estimated to reach 1.5 billion, which will represent nearly 16% of the world’s population. Moreover, the World Health Organization (WHO), 422 million people suffered from some form of diabeties in 2014, and the number is expected to continue swelling in the near future. TMR Research www.tmrresearch.com
MICROALBUMINURIA MARKET 3REGIONAL ASSESSMENT Geographically,theglobalmicroalbuminuriamarketcanbedividedinto North America, Asia Pacific, Europe, South America, and rest of the world. Currently, North America serves the maximum demand due to robust healthcare infrastructure in the countries such as the U.S. and Canada. However, regional markets of South and East Asia, Europe, South America, and Africa are also expected to extend the demand during the forecast period due to high prevalence rate of diabetic patientsintheseregions. TMR Research www.tmrresearch.com
MICROALBUMINURIA MARKET 4COMPETITVE ANALYSIS Some microalbuminuria market are Novartis AG, Sanofi, Alfa Wassermann S.p.A, Steno Diabetes Center A/S, Takeda Pharmaceutical Company, Ltd., Company, AstraZeneca Plc, AbbVie Inc. , Fondazione Mario Negri Sud, and Daiichi Sankyo Company, Ltd. of the key players currently operational in Bristol-Myers Squibb TMR Research www.tmrresearch.com
TMR Research www.tmrresearch.com Sample Discount Check link in description